Report
Nyxoah - H1 2023 results
Yesterday evening Nyxoah published its H1 23 results and held a conference call. Q2 23 results were in line with consensus. The transitory issues that impacted revenues in Q1 are now solved. Management is confident about current business momentum and future growth in Germany. Operating-wise, the US pivotal DREAM trial is progressing well with top-line readouts still on track to be published in Q1 24. As a reminder, this is the next key catalyst for the company. Financing-wise, Nyxoah benefits from a comfortable cash position providing runway until late 2024. Management indicated that, as expected, additional funding will be needed
Underlying
Nyxoah
Provider
Degroof Petercam
We are an investment house with Belgian roots founded on more than 150 years of trust.
As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.
Laura Roba
Other Reports on these Companies
Other Reports from Degroof Petercam
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.